214 related articles for article (PubMed ID: 33318171)
21. IMP3 Stabilization of WNT5B mRNA Facilitates TAZ Activation in Breast Cancer.
Samanta S; Guru S; Elaimy AL; Amante JJ; Ou J; Yu J; Zhu LJ; Mercurio AM
Cell Rep; 2018 May; 23(9):2559-2567. PubMed ID: 29847788
[TBL] [Abstract][Full Text] [Related]
22. Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity.
Schaeffler A; Gross P; Buettner R; Bollheimer C; Buechler C; Neumeier M; Kopp A; Schoelmerich J; Falk W
Immunology; 2009 Feb; 126(2):233-45. PubMed ID: 18624726
[TBL] [Abstract][Full Text] [Related]
23. Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis.
Li YW; Shen H; Frangou C; Yang N; Guo J; Xu B; Bshara W; Shepherd L; Zhu Q; Wang J; Hu Q; Liu S; Morrison CD; Sun P; Zhang J
Cell Cycle; 2015; 14(1):146-56. PubMed ID: 25602524
[TBL] [Abstract][Full Text] [Related]
24. Lack of platelet-activating factor receptor protects mice against diet-induced adipose inflammation and insulin-resistance despite fat pad expansion.
Menezes-Garcia Z; Oliveira MC; Lima RL; Soriani FM; Cisalpino D; Botion LM; Teixeira MM; Souza DG; Ferreira AV
Obesity (Silver Spring); 2014 Mar; 22(3):663-72. PubMed ID: 24339378
[TBL] [Abstract][Full Text] [Related]
25. TAZ maintains telomere length in TNBC cells by mediating Rad51C expression.
Yang L; Wang B; Jiao X; Zhou C; Chen S; Gao X; Sun W; Song S; Li J; Liu J; Wang Y; Liu P
Breast Cancer Res; 2021 Sep; 23(1):89. PubMed ID: 34488828
[TBL] [Abstract][Full Text] [Related]
26. Resistin knockout mice exhibit impaired adipocyte glucose-dependent insulinotropic polypeptide receptor (GIPR) expression.
Kim SJ; Nian C; McIntosh CH
Diabetes; 2013 Feb; 62(2):471-7. PubMed ID: 23002036
[TBL] [Abstract][Full Text] [Related]
27. Resistin is co-secreted with adiponectin in white mouse adipocytes.
Musovic S; Shrestha MM; Komai AM; Olofsson CS
Biochem Biophys Res Commun; 2021 Jan; 534():707-713. PubMed ID: 33261886
[TBL] [Abstract][Full Text] [Related]
28. Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver.
Kim K; Kang JK; Jung YH; Lee SB; Rametta R; Dongiovanni P; Valenti L; Pajvani UB
Nat Commun; 2021 Mar; 12(1):1822. PubMed ID: 33758172
[TBL] [Abstract][Full Text] [Related]
29. STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling.
Zheng L; Xiang C; Li X; Guo Q; Gao L; Ni H; Xia Y; Xi T
J Hematol Oncol; 2018 May; 11(1):72. PubMed ID: 29848346
[TBL] [Abstract][Full Text] [Related]
30. PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways.
Zhao Y; Montminy T; Azad T; Lightbody E; Hao Y; SenGupta S; Asselin E; Nicol C; Yang X
Mol Cancer Res; 2018 Jun; 16(6):1046-1058. PubMed ID: 29545474
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms regulating adipocyte expression of resistin.
Hartman HB; Hu X; Tyler KX; Dalal CK; Lazar MA
J Biol Chem; 2002 May; 277(22):19754-61. PubMed ID: 11901161
[TBL] [Abstract][Full Text] [Related]
32. Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.
Liu J; Ye L; Li Q; Wu X; Wang B; Ouyang Y; Yuan Z; Li J; Lin C
J Pathol; 2018 Jan; 244(1):71-83. PubMed ID: 28991374
[TBL] [Abstract][Full Text] [Related]
33. Obesity-induced MBD2_v2 expression promotes tumor-initiating triple-negative breast cancer stem cells.
Teslow EA; Mitrea C; Bao B; Mohammad RM; Polin LA; Dyson G; Purrington KS; Bollig-Fischer A
Mol Oncol; 2019 Apr; 13(4):894-908. PubMed ID: 30636104
[TBL] [Abstract][Full Text] [Related]
34. A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer.
Shreberk-Shaked M; Dassa B; Sinha S; Di Agostino S; Azuri I; Mukherjee S; Aylon Y; Blandino G; Ruppin E; Oren M
Cancer Res; 2020 Oct; 80(19):4145-4157. PubMed ID: 32816858
[TBL] [Abstract][Full Text] [Related]
35. miR‑574‑5p attenuates proliferation, migration and EMT in triple‑negative breast cancer cells by targeting BCL11A and SOX2 to inhibit the SKIL/TAZ/CTGF axis.
Zhang KJ; Hu Y; Luo N; Li X; Chen FY; Yuan JQ; Guo L
Int J Oncol; 2020 May; 56(5):1240-1251. PubMed ID: 32319565
[TBL] [Abstract][Full Text] [Related]
36. TWIST1-mediated transcriptional activation of PDGFRβ in breast cancer stem cells promotes tumorigenesis and metastasis.
Yeeravalli R; Kaushik K; Das A
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166141. PubMed ID: 33845139
[TBL] [Abstract][Full Text] [Related]
37. Phorbaketal A inhibits adipogenic differentiation through the suppression of PPARγ-mediated gene transcription by TAZ.
Byun MR; Lee CH; Hwang JH; Kim AR; Moon SA; Sung MK; Roh JR; Hwang ES; Hong JH
Eur J Pharmacol; 2013 Oct; 718(1-3):181-7. PubMed ID: 24036109
[TBL] [Abstract][Full Text] [Related]
38. Effect of PPAR-delta agonist on the expression of visfatin, adiponectin, and resistin in rat adipose tissue and 3T3-L1 adipocytes.
Choi KC; Lee SY; Yoo HJ; Ryu OH; Lee KW; Kim SM; Baik SH; Choi KM
Biochem Biophys Res Commun; 2007 May; 357(1):62-7. PubMed ID: 17418807
[TBL] [Abstract][Full Text] [Related]
39. Resistin mitigates stemness and metabolic profile of human adipose-derived mesenchymal stem cells via insulin resistance.
Rawal K; Purohit KM; Patel TP; Karont N; Gupta S
Cytokine; 2021 Feb; 138():155374. PubMed ID: 33271386
[TBL] [Abstract][Full Text] [Related]
40. Adipocyte-specific expression of murine resistin is mediated by synergism between peroxisome proliferator-activated receptor gamma and CCAAT/enhancer-binding proteins.
Tomaru T; Steger DJ; Lefterova MI; Schupp M; Lazar MA
J Biol Chem; 2009 Mar; 284(10):6116-25. PubMed ID: 19126543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
